Status:
UNKNOWN
Vasopressin Injection Technique to Preserve Ovarian Reserve in Surgery for Unilateral Ovarian Endometriomas
Lead Sponsor:
Yonsei University
Conditions:
Unilateral Ovarian Endometrioma
Eligibility:
FEMALE
25-45 years
Phase:
NA
Brief Summary
Endometriosis is a common disease with an incidence rate of 15% in women of childbearing age, and is a chronic disease that significantly affects women's quality of life by causing two problems: pain ...
Detailed Description
Endometriosis is a common disease with an incidence rate of 15% in women of childbearing age, and is a chronic disease that significantly affects women's quality of life by causing two problems: pain ...
Eligibility Criteria
Inclusion
- Subjects undergoing laparoscopic ovarian cyst enucleation for unilateral endometrioma.
- 25≤Age≤45
- 5≤AMH≤7
Exclusion
- Subjects with major medical conditions such as uncontrolled infection, diabetes, severe renal or hepatic disease.
- History of hormonal medication use within 2months
Key Trial Info
Start Date :
October 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2021
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04372836
Start Date
October 30 2018
End Date
August 1 2021
Last Update
May 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology, Yonsei University College of Medicine
Seoul, South Korea